C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/224, 260/264
C07D 487/04 (2006.01) A61K 31/50 (2006.01)
Patent
CA 1336432
Compounds of general formula (I) Image (I) wherein R1 represents an optionally substituted carbocyclic or heterocyclic aryl group, or an optionally substituted alkyl, alkenyl, cycloalkyl or cycloalkenyl group; R2 represents an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl or cycloalkenyl group or an optionally substituted carbocyclic or heterocyclic aryl or aralkyl group; R3 represents a hydrogen atom or an alkyl group; and either X represents an oxygen or sulphur atom, a group -CH2- or a group NR4 where R4 represents a hydrogen atom or a C1-4 alkyl group; and Y represents a group -CH2- or -CH2CH2- or X-Y together represent the group -CH-CH-; and salts and physiologically functional derivatives thereof are useful in the treatment of tumours. Processes for preparing the compounds, intermediates useful in their preparation, pharmaceutical compositions containing them and their use in the treatment of tumours are also described.
574614
Swabey Ogilvy Renault
Wellcome Foundation Limited (the)
LandOfFree
N-imidazo[1,2-b]-pyridazinyl carbamates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-imidazo[1,2-b]-pyridazinyl carbamates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-imidazo[1,2-b]-pyridazinyl carbamates will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1276924